Co-Director, Parker Institute for Cancer Immunotherapy, The University of Texas MD Anderson Cancer Center
Immunology, Immunotherapy, GU Medical Oncology
EDUCATION
BA - Boston University
MA - Boston University
MD/PhD - Pennsylvania State University College of Medicine
Residency - New York Presbyterian Hospital, Weill Cornell Medical Center
Postdoctoral Fellow - Memorial Sloan-Kettering Cancer Center
AWARDS AND ACCOLADES
MD Anderson Cancer Center Faculty Scholar Award, 2012
MD Anderson Cancer Center Emil Frei, III Award for Excellence in Translational Research, 2016
MD Anderson Cancer Center The Julie & Ben Rogers Award for Excellence in Research, 2018
William B. Coley Award in Tumor Immunology by the Cancer Research Institute, 2018
American Society for Clinical Investigation (ASCI), 2018
Women in Science with Excellence (WISE) Honoree, BioHouston, 2020
COMPANIES AND BOARDS
Co-Founder: Apricity Health, Jounce Therapeutics (NASDAQ: JNCE), Agilicell
Scientific Advisory Board: Amgen, Astellas, Kite Pharma (acquired by Gilead), Jounce Therapeutics (NASDAQ: JNCE), Forty Seven, Inc., AstraZeneca Advisory Board, Bristol Myers Squibb Immunology Biomarker Advisory Board, GSK Biomarkers Advisory Board, Hummingbird Bioscience, BioMx, Dragonfly Therapeutics, Codiak Biosciences, Lava Therapuetics, Glympse Bio